AstraZaneca Covid 19 vaccine withdrawn worldwide after manufacturers admitted it can cause dangerous side effect,” reads a ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
In der Europäischen Union ist der Corona-Impfstoff von AstraZeneca nicht mehr zugelassen – das habe „kommerzielle Gründe“, sagt das schwedisch-britische Pharmaunternehmen. Die Nachfrage ...
In March 2024, AstraZeneca requested that the authorization for their COVID-19 vaccine be withdrawn by the European Medicines Agency.
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
Durch sein Corona-Vakzin wurde AstraZeneca einer breiten Öffentlichkeit bekannt. Der Impfstoff ist inzwischen Geschichte. Nun präsentierte Konzernchef Soriot jüngst neue ambitionierte Pläne.
Die AstraZeneca-Anleihe ist handelbar unter der WKN A3KRW4 bzw. der ISIN XS2347663507. Die Anleihe wurde am 03.06.2021 emittiert und hat eine Laufzeit bis 03.06.2029. Das Emissionsvolumen betrug ...
(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion ...
The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union.
After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph ...